Related Experiment Video
Updated: Jan 11, 2026

Cheek Injection Model for Simultaneous Measurement of Pain and Itch-related Behaviors
Published on: September 27, 2019
Therapeutic advances in pruritus as a model of personalized medicine
Kelsey Auyeung1,2,3, Ramsey Kubofcik1,2,3, Brian S Kim1,2,3,4,5
1Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Abstract:
Pruritus or itch is a sensation that evolved to protect humans and other vertebrates against environmental irritants, parasitic infestations and disease-borne insects. However, in the setting of chronic skin inflammation and other medical conditions, pruritus can become pathologic and chronic in nature; indeed, chronic pruritus is defined as itch that persists for greater than 6 weeks and significantly impairs the quality of life of patients. It also poses a major therapeutic challenge. However, recent advances in itch biology have led to the development of novel therapies. This review highlights how new innovations in anti-pruritic medications are revolutionizing the treatment of chronic pruritus and leading to new paradigms of personalized medicine.

